Kandupaarangi ver chooranam for Sura peenisam(Sinusitis) in children

Phase II non randomized clinical study on Sura peenisam(Sinusitis in children) with the evaluation of Siddha trial drug Kandupaarangi ver chooranam in children - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058926

Enrollment

Registered

2023-10-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J019- Acute sinusitis, unspecified

Interventions

Intervention1: Kandupaarangi ver chooranam: Kandupaarangi ver chooranam two to four gram with honey twice a day for 14 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Nasal congestion running nose headache heaviness of head pain and tenderness over para nasal sinuses recurrent sneezing

Exclusion criteria

Exclusion criteria: Vasomotor rhinitis opthalmic headache migraine otitis media congenital anomalies septal defective epistaxis

Design outcomes

Primary

Measure	Time frame
It is assessed by reduction in clinical symptoms like nasal discharge oedema over the sinuses headache nasal obstruction Reduction in visual analog scaleTimepoint: 14 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by reduction in ESR & eosinophil count Xray for paranasal sinuses It is assessed by comparing the safety parameters before and after treatmentTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDr D Muthu Krishnan

Government Siddha Medical College

mahema.siddha@gmail.com9894325360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026